|
|
|
Insider
Information: |
Oclassen Glenn A |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
36,513 |
|
Indirect Shares
|
71,542 |
|
|
Direct
Value |
$81,424 |
|
|
Indirect Value
|
$488,606 |
|
|
Total
Shares |
108,055 |
|
|
Total
Value |
$570,030 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Paratek Pharmaceuticals Inc |
PRTK |
President and CEO, Dir... |
2014-10-30 |
36,513 |
2014-10-30 |
6,121 |
Premium* |
|
Verrica Pharmaceuticals Inc. |
VRCA |
Director |
2018-06-19 |
0 |
2019-01-28 |
65,421 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRCA |
Verrica Pharmaceuticals I... |
Director |
|
2019-01-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
75,000 |
65,421 |
0 |
- |
|
VRCA |
Verrica Pharmaceuticals I... |
Director |
|
2019-01-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,000 |
140,421 |
0 |
- |
|
VRCA |
Verrica Pharmaceuticals I... |
Director |
|
2018-06-19 |
4 |
A |
$0.00 |
$0 |
I/I |
200,734 |
290,421 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2014-10-30 |
4 |
A |
$21.59 |
$229,113 |
D/D |
10,613 |
36,513 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2011-09-19 |
4 |
B |
$5.80 |
$58,000 |
I/I |
10,000 |
73,457 |
2.66 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2011-09-19 |
4 |
B |
$5.80 |
$58,000 |
D/D |
10,000 |
310,800 |
2.81 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2011-08-11 |
4 |
B |
$2.82 |
$6,111 |
D/D |
2,167 |
300,800 |
2.81 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2011-08-10 |
4 |
B |
$2.82 |
$78,509 |
D/D |
27,833 |
298,633 |
2.81 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2009-08-25 |
4/A |
OE |
$0.88 |
$267,820 |
D/D |
226,095 |
263,442 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2009-08-25 |
4 |
OE |
$0.88 |
$267,820 |
D/D |
226,095 |
261,442 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEOOfficer |
|
2009-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,000 |
|
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEOOfficer |
|
2009-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
57,457 |
63,457 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
President and CEO |
|
2009-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
26,647 |
28,647 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|